Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-056437

Chief Operating Officer gave up 6,250 shares (to pay taxes)

  • Chief Operating Officer acquired 12,305 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2025-06-02 Option exercise +12,305 99,883 D
BILINSKY IGOR Chief Operating Officer 2025-06-02 Shares withheld for taxes −6,250 $1.76 $11,000 93,633 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2025-06-02 Option exercise · Restricted Stock Units −3,516 10,549 D
BILINSKY IGOR Chief Operating Officer 2025-06-02 Option exercise · Restricted Stock Units −8,789 61,528 D
Loading xslF345X05/tm2517077-2_4seq1.xml…